April 20, 2021 Uncategorized

Introducing ORG.one: a project to support rapid DNA sequencing of critically endangered species

Mon 19th April 2021 ORG.one is a pilot-stage project designed to support faster, more localised sequencing of critically endangered species, by enabling biologists to rapidly sequence those species close to the sample’s origin, using the latest ultra-long read approaches from Oxford Nanopore.​ Loss of biodiversity is an urgent problem. Genomics can help with existing conservation work, as well as securing the DNA sequence of... Read more

April 20, 2021 Atomic Spectroscopy Chromatography Life Science Tools Mass Spectrometry Molecular Spectroscopy PR/Corporate

Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year

SANTA CLARA, Calif., April 20, 2021  Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and inclusive workplace. Specifically, Agilent ranked No. 83 out of 500 companies on Forbes’s 2021 list of America’s Best Employers... Read more

April 15, 2021 Cell Analysis Tools PR/Corporate

Bio-Techne Announces Launch of Professional Assay Services – Dedicated Source for RNA In Situ Hybridization Assays in Spatial Gene Expression Analysis

APRIL 15, 2021 MINNEAPOLIS, April 15, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Assay Services offered at its Newark, CA laboratory. At the heart of this re-launch is a name change from Pharma... Read more

April 15, 2021 Lab Equipment Product Launch

BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer

BOTHELL, Wash., April 15, 2021 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has launched a new line of high capacity controlled rate freezers (HCRF), with an initial shipment to a leading cell therapy... Read more

April 15, 2021 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Agilent Completes Acquisition of Resolution Bioscience, Expands Role in Fast-growing NGS Market for Precision Oncology

SANTA CLARA, Calif., April 15, 2021  Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of Resolution Bioscience, a leader in the development and commercialization of next-generation sequencing (NGS)-based precision oncology solutions. Resolution Bioscience complements and expands Agilent’s capabilities in NGS-based cancer diagnostics and provides the company with innovative technology to further... Read more

April 14, 2021 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools

Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development

MINNEAPOLIS, April 14, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, for its therapeutic development pipeline. Bio-Techne is a global life sciences company providing... Read more

April 14, 2021 Atomic Spectroscopy Chromatography Life Science Tools Liq. Handling & Robotics Mass Spectrometry Molecular Spectroscopy PR/Corporate

Agilent Named One of Singapore’s Best Employers

Company rises in rank from last year SINGAPORE, April 14, 2021  Agilent Technologies Inc. (NYSE: A) today announced that Agilent Singapore has been recognized as one of Singapore’s Best Employers in 2021 for the second year-in-a-row by The Straits Times, a leading Singapore-based newspaper. Specifically, Agilent is ranked among the top 100 companies and fifth out... Read more

April 14, 2021 M&A, Partnerships

Pressure BioSciences Finalizes Plan to Acquire Global Eco-Friendly Agrochemical Supplier

Company Expects Acquisition to be Accretive with Sustained Profitable Revenue Growth,Leveraging Market-Changing Synergy from PBI’s Ultra Shear Technology Nanoemulsions Platform SOUTH EASTON, MA / ACCESSWIRE / April 14, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to... Read more

April 12, 2021 M&A, Partnerships

Avantor to Acquire Ritter GmbH and its Affiliates; Expands Proprietary Offering for Diagnostic and Drug Discovery Workflows

APRIL 12, 2021- Ritter is a fast-growing, technology leader in high-precision consumables– Combines Ritter’s liquid handling consumables platform for clinical diagnostic testing and life sciences research with Avantor’s offerings for critical lab automation workflows and leading global customer channel– Transaction expected to be immediately accretive to Adjusted Earnings per Share (EPS) upon closure and anticipated... Read more